postherpetic neuralgia
Conditions
Interventions
rTMS group:rTMS treatment with a frequency of 10Hz and a total of 3000 stimuli was performed on the contralateral M1 region of the patient.The treatment cycle is 2 weeks, with 5 consecutive days per w
iTBS group:
Perform iTBS treatment on the contralateral M1 area of the patient with 50Hz intra plexus, 5Hz inter plexus, and a total of 600 stimuli.The treatment cycle is 2 weeks, with 5 consecutive d
Sponsors
Hangzhou First People's Hospital
Eligibility
Sex/Gender
All
Age
50 Years to No maximum
Inclusion criteria
Inclusion criteria: a) Conforming to the IASP diagnosis of postherpetic neuralgia; b) 50 years old or above; c) Persistent pain that persists for one month after the onset of pain; d) Visual Analog Scale (VAS) for Pain Intensity: between 3 and 9 points; e) There is no history of pain control medication adjustment within two weeks before and during the trial period; f) Able to cooperate in completing evaluations and treatments; g) Understand and be willing to participate in this clinical trial and provide a signed informed consent form.
Exclusion criteria
Exclusion criteria: a) Inability to accept iTBS or rTMS interventions (such as pacemakers); b) Individuals who suffer from severe mental illness, aphasia, and cognitive impairment due to various reasons and are unable to cooperate with rehabilitation assessment and treatment in a sitting position; c) Those with other serious diseases such as malignant tumors; d) The mRS score of the patient before this onset is = 2 points; e) Metal implantation surgery; Previous history of epileptic seizures/seizures/treatment with antiepileptic drugs; Pregnant or intending to conceive within six months; f) Individuals who have undergone craniocerebral surgery due to stroke or other reasons; g) Individuals with severe cardiopulmonary dysfunction, extreme weakness, and other unstable conditions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| visual analogue scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| McGillpainquestionnaire;Pittsburgh sleep quality index;SDS/SAS;NLRP3; | — |
Countries
China
Contacts
Public ContactLiang Yu
Hangzhou First People's Hospital
Outcome results
None listed